Cabergoline

규격

81409-90-7CAS 번호

627-031-8EC 번호

(6aR,9R,10aR)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-7-prop-2-enyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamideIUPAC 명칭

C26H37N5O2화학식

451.6 g/mol분자량

cabergoline; 81409-90-7; Dostinex; Cabaser; Cabergolina; Cabergolinum; FCE-21336; Velactis; FCE 21336; DTXSID6022719; LL60K9J05T; 1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea; CHEBI:3286; DTXCID502719; 1-ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea; 1-[(6-allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea; (8R)-6-allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide; (8beta)-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide; Ergoline-8beta-carboxamide, N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propenyl)-; 1-[3-(dimethylamino)propyl]-3-ethyl-1-{[(2R,4R,7R)-6-(prop-2-en-1-yl)-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraen-4-yl]carbonyl}urea; (8R)-6-allyl-N-(3-(dimethylamino)propyl)-N-(ethylcarbamoyl)ergoline-8-carboxamide; 1-((6-allylergoline-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea; 1-[(6-allylergolin-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea; (8beta)-N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propenyl)-ergoline-8-carboxamide; 1-(3-(dimethylamino)propyl)-3-ethyl-1-(((2R,4R,7R)-6-(prop-2-en-1-yl)-6,11-diazatetracyclo(7.6.1.0^(2,7).0^(12,16))hexadeca-1(16),9,12,14-tetraen-4-yl)carbonyl)urea; RefChem:57300; 1-ethyl-2-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'-beta-carbonyl)urea diphosphate; G02CB03; N04BC06; 1-(3-(dimethylamino)propyl)-3-ethyl-1-((2R,4R,7R)-6-(prop-2-en-1-yl)-6,11-diazatetracyclo(7.6.1.02,7.012,16)hexadeca-1(16),9,12,14-tetraene-4-carbonyl)urea; Ergoline-8-carboxamide, N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propen-1-yl)-, (8beta)-; Cabergolinum [Latin]; Cabergolina [Spanish]; MFCD00867887; Cabaseril; (6aR,9R,10aR)-7-allyl-N-(3-(dimethylamino)propyl)-N-(ethylcarbamoyl)-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide; Sogilen; CG-101; Dostinex (TN); (6aR,9R,10aR)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-7-prop-2-enyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide; Cabaser (TN); CAS-81409-90-7; SR-05000001493; BRN 6020775; UNII-LL60K9J05T; Caberlin; Cabergoline CRS; NCGC00167821-01; Cabergoline [USAN:USP:INN:BAN]; Cabergoline; 1-Ethyl-3-[3-(dimethylamino)propyl]-3-[[(6aR,9R,10aR)-7-(prop-2-enyl)-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin-9-yl]carbonyl]urea; Cabergoline (Standard); CABERGOLINE [MI]; CABERGOLINE [INN]; CABERGOLINE [JAN]; CABERGOLINE [USAN]; GTPL37; CABERGOLINE [VANDF]; CABERGOLINE [MART.]; SCHEMBL42292; CABERGOLINE [USP-RS]; CABERGOLINE [WHO-DD]; BIDD:GT0775; orb1308504; Cabergoline (JP18/USP/INN); CHEMBL1201087; SCHEMBL29379722; Cabergoline, >=98% (HPLC); CABERGOLINE [ORANGE BOOK]; MSK1661; KORNTPPJEAJQIU-KJXAQDMKSA-N; CABERGOLINE [EP MONOGRAPH]; HMS2090A09; HMS3886H05; CABERGOLINE [USP MONOGRAPH]; Tox21_112589; BDBM50426497; EBC-27129; HY-15296R; s5842; AKOS015961587; Tox21_112589_1; DB00248; FD19622; CABERGOLINE [EMA EPAR VETERINARY]; NCGC00344544-01; (8beta)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6-(prop-2-en-1-yl)ergoline-8-carboxamide; (8beta)-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-prop-2-en-1-ylergoline-8-carboxamide; AC-26126; Ergoline-8-carboxamide, N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propenyl)-, (8-beta)-; HY-15296; MS-28208; Cabergoline 1000 microg/mL in Acetonitrile; NS00001091; C08187; D00987; F17353; T14853; AB01275484-01; EN300-19767804; Q423308; SR-05000001493-1; SR-05000001493-2; BRD-K86882815-001-01-6; BRD-K86882815-001-03-2; Cabergoline, European Pharmacopoeia (EP) Reference Standard; Cabergoline, United States Pharmacopeia (USP) Reference Standard; 6-allyl-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-ergoline-8beta-carboxamide; N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6-allyl-ergoline-8beta-carboxamide; (6aR,9R,10aR)-7-allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide; (8?)-N-[3-(Dimethylamino)propyl]-N-[(ethylamino)carbonyl] -6-(2-propen-1-yl)-ergoline-8-carboxamide; 1-[3-(dimethylamino)propyl]-3-ethyl-1-[(2R,4R,7R)-6-(prop-2-en-1-yl)-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(15),9,12(16),13-tetraene-4-carbonyl]urea; ERGOLINE-8.BETA.-CARBOXAMIDE, N-(3-(DIMETHYLAMINO)PROPYL)-N-((ETHYLAMINO)CARBONYL)-6-(2-PROPENYL)-; N-[3-(Dimethylamino)propyl]-N-(ethylcarbamoyl)-6-(prop-2-en-1-yl)ergoline-8beta-carboxamide동의어